A case of primary aldosteronism combined with acquired nephrogenic diabetes insipidus
- Authors
- Kim K.; Lee J.H.; Kim S.C.; Cha D.R.; Kang Y.S.
- Issue Date
- 2014
- Publisher
- Elsevier
- Keywords
- Aquaporin; Diabetes insipidus; Hyperaldosteronism; Hypokalemia
- Citation
- Kidney Research and Clinical Practice, v.33, no.4, pp 229 - 233
- Pages
- 5
- Indexed
- SCOPUS
KCI
- Journal Title
- Kidney Research and Clinical Practice
- Volume
- 33
- Number
- 4
- Start Page
- 229
- End Page
- 233
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/9861
- DOI
- 10.1016/j.krcp.2014.09.001
- ISSN
- 2211-9132
2211-9140
- Abstract
- Aldosterone-producing adrenal adenoma can induce various clinical manifestations as a result of chronic exposure to aldosterone. We report a rare case of a 37-year-old man who complained of general weakness and polyuria. He was diagnosed with aldosterone-producing adrenal adenoma and nephrogenic diabetes insipidus. Aldosterone enhances the secretion of potassium in the collecting duct, which can lead to hypokalemia. By contrast, nephrogenic diabetes insipidus, which manifests as polyuria and polydipsia, can occur in several clinical conditions such as acquired tubular disease and those attributed to toxins and congenital causes. Among them, hypokalemia can also damage tubular structures in response to vasopressin. The patient's urine output was >3 L/d and was diluted. Owing to the ineffectiveness of vasopressin, we eventually made a diagnosis of nephrogenic diabetes insipidus. Laparoscopic adrenalectomy and intraoperative kidney biopsy were subsequently performed. The pathologic finding of kidney biopsy revealed a decrease in aquaporin-2 on immunohistochemical stain. © 2014. The Korean Society of Nephrology. Published by Elsevier. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Nephrology and Hypertension > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.